カテゴリー： Market Monitor Global, 世界, 医療/バイオ

心臓ヘルスソリューションのグローバル市場展望 2023年-2029年：心血管画像検査、血圧測定、心電図測定、その他

◆英語タイトル：Cardiac Health Solutions Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12282）

◆商品コード：MMG23DC12282
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：129
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の心臓ヘルスソリューション市場規模と予測を収録しています。・世界の心臓ヘルスソリューション市場：売上、2018年-2023年、2024年-2029年
・世界の心臓ヘルスソリューション市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の心臓ヘルスソリューション市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「心血管画像検査」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

心臓ヘルスソリューションのグローバル主要企業は、CARDIO HEALTH SOLUTIONS、 Biotrial、 Banook Group、 Bioclinica、 Certara L.P.、 Celerion, Inc、 ERT, Inc、 Laboratory Corporation of America Holdings、 Medpace Holdings, Inc.、 Ncardia AG、 Richmond Pharmacology、 PhysioStim、 IQVIA、 BioTelemetry, Inc、 Pharmaceutical Product Development, LLC、 Shanghai Medicilon Inc、 SGS SA、 Spaulding Clinical Research, LLCなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、心臓ヘルスソリューションのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の心臓ヘルスソリューション市場：タイプ別、2018年-2023年、2024年-2029年
世界の心臓ヘルスソリューション市場：タイプ別市場シェア、2022年
・心血管画像検査、血圧測定、心電図測定、その他

世界の心臓ヘルスソリューション市場：用途別、2018年-2023年、2024年-2029年
世界の心臓ヘルスソリューション市場：用途別市場シェア、2022年
・バイオ医薬品企業、研究受託機関（CRO）、その他

世界の心臓ヘルスソリューション市場：地域・国別、2018年-2023年、2024年-2029年
世界の心臓ヘルスソリューション市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における心臓ヘルスソリューションのグローバル売上、2018年-2023年
・主要企業における心臓ヘルスソリューションのグローバル売上シェア、2022年
・主要企業における心臓ヘルスソリューションのグローバル販売量、2018年-2023年
・主要企業における心臓ヘルスソリューションのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
CARDIO HEALTH SOLUTIONS、 Biotrial、 Banook Group、 Bioclinica、 Certara L.P.、 Celerion, Inc、 ERT, Inc、 Laboratory Corporation of America Holdings、 Medpace Holdings, Inc.、 Ncardia AG、 Richmond Pharmacology、 PhysioStim、 IQVIA、 BioTelemetry, Inc、 Pharmaceutical Product Development, LLC、 Shanghai Medicilon Inc、 SGS SA、 Spaulding Clinical Research, LLC

*************************************************************

・調査・分析レポートの概要
心臓ヘルスソリューション市場の定義
市場セグメント
世界の心臓ヘルスソリューション市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の心臓ヘルスソリューション市場規模
世界の心臓ヘルスソリューション市場規模：2022年 VS 2029年
世界の心臓ヘルスソリューション市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの心臓ヘルスソリューションの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の心臓ヘルスソリューション製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：心血管画像検査、血圧測定、心電図測定、その他
心臓ヘルスソリューションのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：バイオ医薬品企業、研究受託機関（CRO）、その他
心臓ヘルスソリューションの用途別グローバル売上・予測

・地域別市場分析
地域別心臓ヘルスソリューション市場規模 2022年と2029年
地域別心臓ヘルスソリューション売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
CARDIO HEALTH SOLUTIONS、 Biotrial、 Banook Group、 Bioclinica、 Certara L.P.、 Celerion, Inc、 ERT, Inc、 Laboratory Corporation of America Holdings、 Medpace Holdings, Inc.、 Ncardia AG、 Richmond Pharmacology、 PhysioStim、 IQVIA、 BioTelemetry, Inc、 Pharmaceutical Product Development, LLC、 Shanghai Medicilon Inc、 SGS SA、 Spaulding Clinical Research, LLC
...

This research report provides a comprehensive analysis of the Cardiac Health Solutions market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cardiac Health Solutions market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cardiac Health Solutions, challenges faced by the industry, and potential opportunities for market players.
The global Cardiac Health Solutions market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cardiac Health Solutions market presents opportunities for various stakeholders, including Biopharmaceuticals Companies, Contract Research Organization(CRO). Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cardiac Health Solutions market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cardiac Health Solutions market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Cardiac Health Solutions market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cardiac Health Solutions market.
Market Overview: The report provides a comprehensive overview of the Cardiac Health Solutions market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Cardiovascular Imaging, Blood Pressure Measurement), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cardiac Health Solutions market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cardiac Health Solutions market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cardiac Health Solutions market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cardiac Health Solutions market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cardiac Health Solutions market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cardiac Health Solutions market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cardiac Health Solutions, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cardiac Health Solutions market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cardiac Health Solutions market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cardiovascular Imaging
Blood Pressure Measurement
Ecg Measurement
Others
Market segment by Application
Biopharmaceuticals Companies
Contract Research Organization(CRO)
Others
Global Cardiac Health Solutions Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CARDIO HEALTH SOLUTIONS
Biotrial
Banook Group
Bioclinica
Certara L.P.
Celerion, Inc
ERT, Inc
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Ncardia AG
Richmond Pharmacology
PhysioStim
IQVIA
BioTelemetry, Inc
Pharmaceutical Product Development, LLC
Shanghai Medicilon Inc
SGS SA
Spaulding Clinical Research, LLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiac Health Solutions, market overview.
Chapter 2: Global Cardiac Health Solutions market size in revenue.
Chapter 3: Detailed analysis of Cardiac Health Solutions company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiac Health Solutions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cardiac Health Solutions Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiac Health Solutions Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiac Health Solutions Overall Market Size
2.1 Global Cardiac Health Solutions Market Size: 2022 VS 2029
2.2 Global Cardiac Health Solutions Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Health Solutions Players in Global Market
3.2 Top Global Cardiac Health Solutions Companies Ranked by Revenue
3.3 Global Cardiac Health Solutions Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Health Solutions Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cardiac Health Solutions Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Health Solutions Players in Global Market
3.6.1 List of Global Tier 1 Cardiac Health Solutions Companies
3.6.2 List of Global Tier 2 and Tier 3 Cardiac Health Solutions Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cardiac Health Solutions Market Size Markets, 2022 & 2029
4.1.2 Cardiovascular Imaging
4.1.3 Blood Pressure Measurement
4.1.4 Ecg Measurement
4.1.5 Others
4.2 By Type – Global Cardiac Health Solutions Revenue & Forecasts
4.2.1 By Type – Global Cardiac Health Solutions Revenue, 2018-2023
4.2.2 By Type – Global Cardiac Health Solutions Revenue, 2024-2029
4.2.3 By Type – Global Cardiac Health Solutions Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cardiac Health Solutions Market Size, 2022 & 2029
5.1.2 Biopharmaceuticals Companies
5.1.3 Contract Research Organization(CRO)
5.1.4 Others
5.2 By Application – Global Cardiac Health Solutions Revenue & Forecasts
5.2.1 By Application – Global Cardiac Health Solutions Revenue, 2018-2023
5.2.2 By Application – Global Cardiac Health Solutions Revenue, 2024-2029
5.2.3 By Application – Global Cardiac Health Solutions Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cardiac Health Solutions Market Size, 2022 & 2029
6.2 By Region – Global Cardiac Health Solutions Revenue & Forecasts
6.2.1 By Region – Global Cardiac Health Solutions Revenue, 2018-2023
6.2.2 By Region – Global Cardiac Health Solutions Revenue, 2024-2029
6.2.3 By Region – Global Cardiac Health Solutions Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cardiac Health Solutions Revenue, 2018-2029
6.3.2 US Cardiac Health Solutions Market Size, 2018-2029
6.3.3 Canada Cardiac Health Solutions Market Size, 2018-2029
6.3.4 Mexico Cardiac Health Solutions Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cardiac Health Solutions Revenue, 2018-2029
6.4.2 Germany Cardiac Health Solutions Market Size, 2018-2029
6.4.3 France Cardiac Health Solutions Market Size, 2018-2029
6.4.4 U.K. Cardiac Health Solutions Market Size, 2018-2029
6.4.5 Italy Cardiac Health Solutions Market Size, 2018-2029
6.4.6 Russia Cardiac Health Solutions Market Size, 2018-2029
6.4.7 Nordic Countries Cardiac Health Solutions Market Size, 2018-2029
6.4.8 Benelux Cardiac Health Solutions Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cardiac Health Solutions Revenue, 2018-2029
6.5.2 China Cardiac Health Solutions Market Size, 2018-2029
6.5.3 Japan Cardiac Health Solutions Market Size, 2018-2029
6.5.4 South Korea Cardiac Health Solutions Market Size, 2018-2029
6.5.5 Southeast Asia Cardiac Health Solutions Market Size, 2018-2029
6.5.6 India Cardiac Health Solutions Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cardiac Health Solutions Revenue, 2018-2029
6.6.2 Brazil Cardiac Health Solutions Market Size, 2018-2029
6.6.3 Argentina Cardiac Health Solutions Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cardiac Health Solutions Revenue, 2018-2029
6.7.2 Turkey Cardiac Health Solutions Market Size, 2018-2029
6.7.3 Israel Cardiac Health Solutions Market Size, 2018-2029
6.7.4 Saudi Arabia Cardiac Health Solutions Market Size, 2018-2029
6.7.5 UAE Cardiac Health Solutions Market Size, 2018-2029
7 Cardiac Health Solutions Companies Profiles
7.1 CARDIO HEALTH SOLUTIONS
7.1.1 CARDIO HEALTH SOLUTIONS Company Summary
7.1.2 CARDIO HEALTH SOLUTIONS Business Overview
7.1.3 CARDIO HEALTH SOLUTIONS Cardiac Health Solutions Major Product Offerings
7.1.4 CARDIO HEALTH SOLUTIONS Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.1.5 CARDIO HEALTH SOLUTIONS Key News & Latest Developments
7.2 Biotrial
7.2.1 Biotrial Company Summary
7.2.2 Biotrial Business Overview
7.2.3 Biotrial Cardiac Health Solutions Major Product Offerings
7.2.4 Biotrial Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.2.5 Biotrial Key News & Latest Developments
7.3 Banook Group
7.3.1 Banook Group Company Summary
7.3.2 Banook Group Business Overview
7.3.3 Banook Group Cardiac Health Solutions Major Product Offerings
7.3.4 Banook Group Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.3.5 Banook Group Key News & Latest Developments
7.4 Bioclinica
7.4.1 Bioclinica Company Summary
7.4.2 Bioclinica Business Overview
7.4.3 Bioclinica Cardiac Health Solutions Major Product Offerings
7.4.4 Bioclinica Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.4.5 Bioclinica Key News & Latest Developments
7.5 Certara L.P.
7.5.1 Certara L.P. Company Summary
7.5.2 Certara L.P. Business Overview
7.5.3 Certara L.P. Cardiac Health Solutions Major Product Offerings
7.5.4 Certara L.P. Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.5.5 Certara L.P. Key News & Latest Developments
7.6 Celerion, Inc
7.6.1 Celerion, Inc Company Summary
7.6.2 Celerion, Inc Business Overview
7.6.3 Celerion, Inc Cardiac Health Solutions Major Product Offerings
7.6.4 Celerion, Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.6.5 Celerion, Inc Key News & Latest Developments
7.7 ERT, Inc
7.7.1 ERT, Inc Company Summary
7.7.2 ERT, Inc Business Overview
7.7.3 ERT, Inc Cardiac Health Solutions Major Product Offerings
7.7.4 ERT, Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.7.5 ERT, Inc Key News & Latest Developments
7.8 Laboratory Corporation of America Holdings
7.8.1 Laboratory Corporation of America Holdings Company Summary
7.8.2 Laboratory Corporation of America Holdings Business Overview
7.8.3 Laboratory Corporation of America Holdings Cardiac Health Solutions Major Product Offerings
7.8.4 Laboratory Corporation of America Holdings Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.8.5 Laboratory Corporation of America Holdings Key News & Latest Developments
7.9 Medpace Holdings, Inc.
7.9.1 Medpace Holdings, Inc. Company Summary
7.9.2 Medpace Holdings, Inc. Business Overview
7.9.3 Medpace Holdings, Inc. Cardiac Health Solutions Major Product Offerings
7.9.4 Medpace Holdings, Inc. Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.9.5 Medpace Holdings, Inc. Key News & Latest Developments
7.10 Ncardia AG
7.10.1 Ncardia AG Company Summary
7.10.2 Ncardia AG Business Overview
7.10.3 Ncardia AG Cardiac Health Solutions Major Product Offerings
7.10.4 Ncardia AG Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.10.5 Ncardia AG Key News & Latest Developments
7.11 Richmond Pharmacology
7.11.1 Richmond Pharmacology Company Summary
7.11.2 Richmond Pharmacology Business Overview
7.11.3 Richmond Pharmacology Cardiac Health Solutions Major Product Offerings
7.11.4 Richmond Pharmacology Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.11.5 Richmond Pharmacology Key News & Latest Developments
7.12 PhysioStim
7.12.1 PhysioStim Company Summary
7.12.2 PhysioStim Business Overview
7.12.3 PhysioStim Cardiac Health Solutions Major Product Offerings
7.12.4 PhysioStim Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.12.5 PhysioStim Key News & Latest Developments
7.13 IQVIA
7.13.1 IQVIA Company Summary
7.13.2 IQVIA Business Overview
7.13.3 IQVIA Cardiac Health Solutions Major Product Offerings
7.13.4 IQVIA Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.13.5 IQVIA Key News & Latest Developments
7.14 BioTelemetry, Inc
7.14.1 BioTelemetry, Inc Company Summary
7.14.2 BioTelemetry, Inc Business Overview
7.14.3 BioTelemetry, Inc Cardiac Health Solutions Major Product Offerings
7.14.4 BioTelemetry, Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.14.5 BioTelemetry, Inc Key News & Latest Developments
7.15 Pharmaceutical Product Development, LLC
7.15.1 Pharmaceutical Product Development, LLC Company Summary
7.15.2 Pharmaceutical Product Development, LLC Business Overview
7.15.3 Pharmaceutical Product Development, LLC Cardiac Health Solutions Major Product Offerings
7.15.4 Pharmaceutical Product Development, LLC Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.15.5 Pharmaceutical Product Development, LLC Key News & Latest Developments
7.16 Shanghai Medicilon Inc
7.16.1 Shanghai Medicilon Inc Company Summary
7.16.2 Shanghai Medicilon Inc Business Overview
7.16.3 Shanghai Medicilon Inc Cardiac Health Solutions Major Product Offerings
7.16.4 Shanghai Medicilon Inc Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.16.5 Shanghai Medicilon Inc Key News & Latest Developments
7.17 SGS SA
7.17.1 SGS SA Company Summary
7.17.2 SGS SA Business Overview
7.17.3 SGS SA Cardiac Health Solutions Major Product Offerings
7.17.4 SGS SA Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.17.5 SGS SA Key News & Latest Developments
7.18 Spaulding Clinical Research, LLC
7.18.1 Spaulding Clinical Research, LLC Company Summary
7.18.2 Spaulding Clinical Research, LLC Business Overview
7.18.3 Spaulding Clinical Research, LLC Cardiac Health Solutions Major Product Offerings
7.18.4 Spaulding Clinical Research, LLC Cardiac Health Solutions Revenue in Global Market (2018-2023)
7.18.5 Spaulding Clinical Research, LLC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Cardiac Health Solutions Market Opportunities & Trends in Global Market
Table 2. Cardiac Health Solutions Market Drivers in Global Market
Table 3. Cardiac Health Solutions Market Restraints in Global Market
Table 4. Key Players of Cardiac Health Solutions in Global Market
Table 5. Top Cardiac Health Solutions Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cardiac Health Solutions Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cardiac Health Solutions Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cardiac Health Solutions Product Type
Table 9. List of Global Tier 1 Cardiac Health Solutions Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cardiac Health Solutions Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cardiac Health Solutions Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cardiac Health Solutions Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cardiac Health Solutions Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Cardiac Health Solutions Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cardiac Health Solutions Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cardiac Health Solutions Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Cardiac Health Solutions Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cardiac Health Solutions Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cardiac Health Solutions Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cardiac Health Solutions Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cardiac Health Solutions Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cardiac Health Solutions Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cardiac Health Solutions Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cardiac Health Solutions Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cardiac Health Solutions Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cardiac Health Solutions Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cardiac Health Solutions Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cardiac Health Solutions Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cardiac Health Solutions Revenue, (US$, Mn), 2024-2029
Table 30. CARDIO HEALTH SOLUTIONS Company Summary
Table 31. CARDIO HEALTH SOLUTIONS Cardiac Health Solutions Product Offerings
Table 32. CARDIO HEALTH SOLUTIONS Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 33. CARDIO HEALTH SOLUTIONS Key News & Latest Developments
Table 34. Biotrial Company Summary
Table 35. Biotrial Cardiac Health Solutions Product Offerings
Table 36. Biotrial Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 37. Biotrial Key News & Latest Developments
Table 38. Banook Group Company Summary
Table 39. Banook Group Cardiac Health Solutions Product Offerings
Table 40. Banook Group Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 41. Banook Group Key News & Latest Developments
Table 42. Bioclinica Company Summary
Table 43. Bioclinica Cardiac Health Solutions Product Offerings
Table 44. Bioclinica Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 45. Bioclinica Key News & Latest Developments
Table 46. Certara L.P. Company Summary
Table 47. Certara L.P. Cardiac Health Solutions Product Offerings
Table 48. Certara L.P. Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 49. Certara L.P. Key News & Latest Developments
Table 50. Celerion, Inc Company Summary
Table 51. Celerion, Inc Cardiac Health Solutions Product Offerings
Table 52. Celerion, Inc Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 53. Celerion, Inc Key News & Latest Developments
Table 54. ERT, Inc Company Summary
Table 55. ERT, Inc Cardiac Health Solutions Product Offerings
Table 56. ERT, Inc Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 57. ERT, Inc Key News & Latest Developments
Table 58. Laboratory Corporation of America Holdings Company Summary
Table 59. Laboratory Corporation of America Holdings Cardiac Health Solutions Product Offerings
Table 60. Laboratory Corporation of America Holdings Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 61. Laboratory Corporation of America Holdings Key News & Latest Developments
Table 62. Medpace Holdings, Inc. Company Summary
Table 63. Medpace Holdings, Inc. Cardiac Health Solutions Product Offerings
Table 64. Medpace Holdings, Inc. Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 65. Medpace Holdings, Inc. Key News & Latest Developments
Table 66. Ncardia AG Company Summary
Table 67. Ncardia AG Cardiac Health Solutions Product Offerings
Table 68. Ncardia AG Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 69. Ncardia AG Key News & Latest Developments
Table 70. Richmond Pharmacology Company Summary
Table 71. Richmond Pharmacology Cardiac Health Solutions Product Offerings
Table 72. Richmond Pharmacology Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 73. Richmond Pharmacology Key News & Latest Developments
Table 74. PhysioStim Company Summary
Table 75. PhysioStim Cardiac Health Solutions Product Offerings
Table 76. PhysioStim Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 77. PhysioStim Key News & Latest Developments
Table 78. IQVIA Company Summary
Table 79. IQVIA Cardiac Health Solutions Product Offerings
Table 80. IQVIA Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 81. IQVIA Key News & Latest Developments
Table 82. BioTelemetry, Inc Company Summary
Table 83. BioTelemetry, Inc Cardiac Health Solutions Product Offerings
Table 84. BioTelemetry, Inc Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 85. BioTelemetry, Inc Key News & Latest Developments
Table 86. Pharmaceutical Product Development, LLC Company Summary
Table 87. Pharmaceutical Product Development, LLC Cardiac Health Solutions Product Offerings
Table 88. Pharmaceutical Product Development, LLC Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 89. Pharmaceutical Product Development, LLC Key News & Latest Developments
Table 90. Shanghai Medicilon Inc Company Summary
Table 91. Shanghai Medicilon Inc Cardiac Health Solutions Product Offerings
Table 92. Shanghai Medicilon Inc Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 93. Shanghai Medicilon Inc Key News & Latest Developments
Table 94. SGS SA Company Summary
Table 95. SGS SA Cardiac Health Solutions Product Offerings
Table 96. SGS SA Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 97. SGS SA Key News & Latest Developments
Table 98. Spaulding Clinical Research, LLC Company Summary
Table 99. Spaulding Clinical Research, LLC Cardiac Health Solutions Product Offerings
Table 100. Spaulding Clinical Research, LLC Cardiac Health Solutions Revenue (US$, Mn) & (2018-2023)
Table 101. Spaulding Clinical Research, LLC Key News & Latest Developments
List of Figures
Figure 1. Cardiac Health Solutions Segment by Type in 2022
Figure 2. Cardiac Health Solutions Segment by Application in 2022
Figure 3. Global Cardiac Health Solutions Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cardiac Health Solutions Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cardiac Health Solutions Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cardiac Health Solutions Revenue in 2022
Figure 8. By Type - Global Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cardiac Health Solutions Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cardiac Health Solutions Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 16. US Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 20. Germany Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 21. France Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 28. China Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 32. India Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 34. Brazil Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cardiac Health Solutions Revenue Market Share, 2018-2029
Figure 37. Turkey Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cardiac Health Solutions Revenue, (US$, Mn), 2018-2029
Figure 41. CARDIO HEALTH SOLUTIONS Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Biotrial Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Banook Group Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bioclinica Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Certara L.P. Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Celerion, Inc Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ERT, Inc Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Laboratory Corporation of America Holdings Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Medpace Holdings, Inc. Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Ncardia AG Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Richmond Pharmacology Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. PhysioStim Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. IQVIA Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. BioTelemetry, Inc Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Pharmaceutical Product Development, LLC Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Shanghai Medicilon Inc Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. SGS SA Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Spaulding Clinical Research, LLC Cardiac Health Solutions Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心臓ヘルスソリューションのグローバル市場展望 2023年-2029年：心血管画像検査、血圧測定、心電図測定、その他(Cardiac Health Solutions Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

心臓ヘルスソリューションのグローバル市場展望 2023年-2029年：心血管画像検査、血圧測定、心電図測定、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp